Corrigendum: Improving therapy of pharmacoresistant epilepsies: The role of fenfluramine

Front Pharmacol. 2023 Jan 5:13:1116575. doi: 10.3389/fphar.2022.1116575. eCollection 2022.

Authors

Gianluca Dini¹, Eleonora Tulli¹, Giovanni Battista Dell'Isola¹, Elisabetta Mencaroni¹, Giuseppe Di Cara¹, Pasquale Striano^{2

3}, Alberto Verrotti¹

Affiliations

¹ Department of Pediatrics, University of Perugia, Perugia, Italy.
² Pediatric Neurology and Muscular Diseases Unit, IRCCS "G. Gaslini" Institute, Genoa, Italy.
³ Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.

Abstract

[This corrects the article DOI: 10.3389/fphar.2022.832929.].

Keywords: Dravet syndrome; Lennox-Gastaut syndrome; anti-seizure medication (ASM); fenfluramine; pharmacoresistant epilepsy.

Copyright © 2023 Dini, Tulli, Dell’Isola, Mencaroni, Di Cara, Striano and Verrotti.

Publication types

Published Erratum